STOCK TITAN

Insider Raymond Woo to sell 11,112 CBLL (CBLL) shares under Rule 144

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Raymond Woo filed a notice to sell 11,112 common shares of CBLL under Rule 144. The planned sale, through Fidelity Brokerage Services on NASDAQ, has an aggregate market value of $231,129.60 and is targeted for approximately February 2, 2026.

The shares were acquired by exercising stock options on February 2, 2026 that were originally granted on July 7, 2021 and February 16, 2023, for 1,472 and 9,640 shares respectively, paid in cash. Over the past three months, Woo has sold 11,112 CBLL common shares on each of November 11, 2025, December 1, 2025, and January 2, 2026, for gross proceeds of $136,496.56, $184,424.30, and $235,228.09.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

CeriBell, Inc.

NASDAQ:CBLL

CBLL Rankings

CBLL Latest News

CBLL Latest SEC Filings

CBLL Stock Data

717.43M
29.28M
10.43%
84.44%
3.61%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
SUNNYVALE